Donald Abrams, MD

Cancer and integrative medicine specialist

Dr. Donald I. Abrams is a cancer and integrative medicine specialist at the UCSF Osher Center for Integrative Medicine at Mount Zion. Abrams provides integrative medicine consultations for cancer patients and has completed research in complementary and alternative therapies including mind-body treatments, botanical therapies, medical use of marijuana and traditional Chinese medicine herbal therapies.

In addition to his role at the Osher Center, Abrams continues to practice general oncology at Zuckerberg San Francisco General Hospital, where he was chief of Hematology-Oncology from 2003 to 2017. Previously at the forefront in HIV/AIDS research and treatment, Abrams completed a fellowship in integrative medicine at the University of Arizona in 2004 and subsequently stepped down from HIV practice to devote more time to integrative oncology. He continues to research the health effects of medical cannabis. He co-edited the textbook Integrative Oncology, published by Oxford University Press, with Dr. Andrew Weil. In 2010, Abrams served as president of the Society for Integrative Oncology.

Read a Q&A with Abrams.


Osher Center for Integrative Medicine
1545 Divisadero St., Fourth Floor
San Francisco, CA 94115
Phone: (415) 353-7700
Fax: (415) 353-7358

Monday to Thursday
8 a.m. – 6 p.m.

8 a.m. – 5 p.m.

Academic Title


More about Donald Abrams

Additional Languages



Stanford University School of Medicine 1977


UCSF Medical Center, Hematology 1983


University of Arizona Medical Center, Integrated Medicine 2004

Selected Research and Publications

  1. Cohn DL, El Sadr WM, Abrams DI, Neaton JD, Benator DA, Vernon AA. In Memoriam, Fred Gordin, MD, 1951-2018. Clin Infect Dis. 2018 May 29.
  2. Abrams DI. The therapeutic effects of Cannabis and cannabinoids: An update from the National Academies of Sciences, Engineering and Medicine report. Eur J Intern Med. 2018 Mar; 49:7-11.
  3. Chao C, Silverberg MJ, Chen LH, Xu L, Martínez-Maza O, Abrams DI, Zha HD, Haque R, Said J. Novel tumor markers provide improved prediction of survival after diagnosis of human immunodeficiency virus (HIV)-related diffuse large B-cell lymphoma. Leuk Lymphoma. 2018 Feb; 59(2):321-329.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.